In this article, we are going to take a look at where Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) stands against other most ...
Researchers at the California Institute of Technology (Caltech) have successfully demonstrated multiplex entanglement inside ...
A new quantum-dot display technology uses ions to boost brightness and efficiency while extending screen lifespan and ...
A team of researchers at the Max Planck Institute for Medical Research made a striking discovery—a protein with contradictory ...
In a new study, Northwestern University researchers demonstrated that brewing tea naturally adsorbs heavy metals like lead ...
Ionis Pharmaceuticals, Inc., a commercial-stage biotechnology company, provides RNA-targeted medicines in the United States. The company offers TRYNGOLZA reduces triglyceride levels in adults with ...
In the race to meet the growing global demand for lithium — a critical component in batteries for electric vehicles — a team ...
William Blair issued their Q1 2026 earnings per share (EPS) estimates for Ionis Pharmaceuticals in a report released on Wednesday, February 19th. William Blair analyst M. Minter forecasts that the ...
In a report released on February 23, Paul Matteis from Stifel Nicolaus maintained a Hold rating on Ionis Pharmaceuticals (IONS – Research ...
Find out how negative ionization technology is transforming architecture to create cleaner, more comfortable spaces for ...
Japanese researchers have made a groundbreaking development in fuel cell technology with huge potential for cleaner energy.